查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840715

磁振造影血管血管造影術設備市場（按產品、場強、技術、應用和最終用戶）—全球預測 2025-2032

Magnetic Resonance Angiography Market by Product, Field Strength, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，磁振造影血管造影術設備市場將成長至 76.7 億美元，複合年成長率為 11.38%。

主要市場統計數據
基準年2024年 32.3億美元
預計2025年 36億美元
預測年份：2032年 76.7億美元
複合年成長率（%） 11.38%

簡要概述最新的磁振造影血管攝影創新如何與臨床需求、業務重點和組織決策交叉

磁振造影血管血管造影術(MRA) 為臨床醫師提供各種臨床環境下的非侵入性血管可視化，在影像創新與血管治療途徑之間發揮關鍵作用。近期的技術進步降低了操作複雜性，擴大了臨床適應症，並提高了患者舒適度，從而使 MRA 從一種小眾方法提升為眾多血管工作流程中的重要診斷工具。在序列創新、硬體進步和基於軟體的影像重建技術的推動下，這些發展再形成了臨床醫生的期望和採購優先事項。

因此，診斷影像、臨床研究和設備製造領域的相關人員必須重新評估MRA如何與其更廣泛的診斷策略整合。放射科團隊越來越重視吞吐量和診斷信心，而醫院管理人員則要求設備能夠支援多學科使用且生命週期成本可預測。同時，門診中心和診斷影像提供者正在評估MRA如何在不造成不永續的營運負擔的情況下增強其服務組合。本介紹將MRA置於當代臨床和商業性環境中，強調技術能力、臨床應用和組織決策之間的相互作用。

深入了解重新定義磁振造影血管造影術實踐和採購的硬體、序列和計算趨勢

在硬體、脈衝序列設計和計算影像處理技術的推動下，磁振造影血管攝影 (MRA) 領域正在發生重大變革。高場系統不斷突破信噪比極限，實現更高的空間解析度，而低場系統也因其成本優勢和更高的可及性而重新引發人們的興趣。同時，飛行時間和靜止間隔單次激發等非造影技術日益成熟，減少了對钆類藥物的依賴，並重塑了腎功能不全或需要重複成像的患者的臨床通訊協定。

同時，相位造影序列和先進的造影技術在血流動力學評估方面也得到了改進，有助於更細緻地評估血管血流和病變特徵。人工智慧和機器學習在重建、降噪和自動血管分割方面發揮越來越重要的作用，從而縮短了掃描時間並提高了診斷能力。因此，服務模式和耗材工作流程正在不斷調整，以支援結合高階系統、最佳化序列庫和增值軟體的混合產品。總的來說，這些轉變正在重新定義採購標準和臨床路徑，互通性、可升級性和軟體許可正變得與基本硬體規格一樣具有影響力。

評估 2025 年美國新關稅如何重塑整個磁振造影血管血管造影術設備生態系統的籌資策略、供應鏈和資本規劃

2025年美國新關稅的實施將為MRA相關人員創造一個複雜的環境，影響採購週期、採購決策和供應商關係。與關稅相關的成本壓力可能會提高進口零件和完整影像系統的到岸價格，從而影響醫院、診斷中心和門診機構的資本配置和更換計畫。面對不斷上升的購買成本，許多買家將推遲升級或優先考慮可分階段實施的模組化投資，同時更仔細地審查總體擁有成本，包括維護和耗材供應協議。

此外，關稅政策將鼓勵策略性供應商多元化和近岸外包，促使製造商重組供應鏈，以降低關稅波動帶來的風險。隨著本地生產相對更具吸引力，關稅可能會改變服務供應商和耗材供應商的競爭動態。在這種情況下，採購團隊和臨床負責人必須將供應鏈的彈性納入其採購標準，在短期成本節約的潛力與單一採購的風險之間取得平衡。因此，法規遵循和海關最佳化變得更加重要，相關人員必須鼓勵供應商考慮庫存規劃和合約的靈活性，以便更好地應對意外關稅的影響。總的來說，這些調整將影響整個影像生態系統的資本規劃、供應商談判和營運連續性。

深入的細分綜合揭示了產品類型、場強等級、影像技術、臨床應用和最終用戶概況如何影響 MRA 需求和投資

詳細了解市場細分，可以揭示MRA的臨床需求和投資集中在何處。依產品分析市場，可以清楚發現配件和耗材、持續服務合約以及資本系統之間的價值流，而系統本身則分為高場強和低場強平台，具有不同的臨床能力和生命週期經濟性。這種二分法在僅按場強進行細分時也體現出來，因為高場強和低場強平台針對不同的臨床用例和設施預算。基於技術的細分顯示，造影劑與相位對比、靜態間隔單次激發和飛行時間技術共存，每種技術都貢獻了各自的診斷強度和特定序列的工作流程要求。

應用細分進一步明確了臨床發展軌跡，心血管應用涵蓋主動脈和心臟成像需求，神經血管應用區分顱外和顱內成像，周邊血管應用區分下肢和上肢成像。這些臨床細分與最終用戶細分（學術機構、門診手術中心、診斷影像中心和醫院）相互影響，而這些細分市場的採購週期、臨床吞吐量預期和人員配置模式存在顯著差異。因此，產品、現場能力、技術、應用和最終用戶細分形成了相互重疊的需求區域。追蹤這些交叉點，使相關人員能夠確定投資優先順序、協調服務內容，並設計與每個細分市場營運實際情況相符的臨床檢驗研究。

全面的區域分析，重點介紹美洲、歐洲、中東和非洲以及亞太地區的不同 MRA 採用模式、採購動態和臨床重點

在全球MRA領域，區域動態對技術採用、報銷框架和臨床實踐模式有重大影響。在美洲，臨床網路和大型醫療保健系統通常會推動高效能系統和先進定序文庫的早期採用。歐洲、中東和非洲 (EMEA) 地區既有成熟的市場，擁有成熟的報銷途徑，也有新興的醫療保健系統，優先考慮經濟高效、擴充性的解決方案。監管協調工作和跨境臨床合作進一步塑造了這些地區的需求。在亞太地區，受診斷基礎設施擴張和對非侵入性血管診斷投資增加的推動，都市區的MRA應用正在快速成長，但高所得大都會圈和資源受限地區的市場成熟度差異顯著，在這些地區，低機構體系和精簡的服務模式可能更為實用。

這些地區在臨床指引、訓練流程和服務交付模式上的差異，將影響MRA相對於其他影像方式的定位。因此，供應商和服務供應商應根據地區特性制定合作策略，並充分考慮採購週期、當地臨床專家和當地法規。此外，與區域研究機構和臨床教育計畫合作，可以促進臨床需求和能力匹配地區的應用，而靈活的商業模式則有助於填補資金有限地區的空白。

策略競爭分析重點在於整合硬體、軟體和服務提案如何決定供應商在磁振造影血管血管造影術市場的成功

MRA 生態系統的競爭力日益由硬體、序列庫、後處理軟體和服務協議的整合提案而非單一設備銷售來決定。能夠透過強大的軟體套件（用於血管分割、流量量化和 AI 輔助重建）補充其系統的目標商標產品製造商，正在重視互通性和清晰藍圖的大型醫療保健系統中佔據更有利的地位。同時，專注於耗材、線圈和手術配件的專業供應商則憑藉其臨床適用性、易於整合性和可預測的供應鏈競爭。提供快速維護、遠距離診斷和靈活培訓計劃的服務供應商，為尋求保證運作和員工能力的最終用戶提供了切實的價值。

影像IT提供者與臨床網路之間的策略夥伴關係也正在成為一種差異化因素，它能夠支援縱向資料分析和品質改進計劃，從而擴展MRA的臨床效用。在這種環境下，那些投資於臨床檢驗、提供透明昇級路徑並展現出強大合規性的公司，更有可能贏得複雜且高相關人員的採購決策。對於規模較小的公司而言，專注於利基臨床應用、極具吸引力的經濟價值提案或新穎的造影和非造影技術，有助於建立廣泛的市場地位。最終，成功的關鍵在於，將產品和服務創新與不同臨床環境的營運現實結合，同時透過自適應籌資策略管理供應鏈和關稅相關風險。

為產業領導者提供可操作的策略框架，以最佳化技術投資、供應鏈、臨床檢驗和 MRA 解決方案的商業化

產業領導者應採取多管齊下的策略，加速MRA在醫療領域的應用，同時挖掘臨床價值並降低外部風險。首先，優先投資定序和軟體開發，以顯著縮短掃描時間、提升診斷信心並增強臨床投資報酬率。同時，應多元化供應鏈，探索區域製造或組裝夥伴關係，以減輕關稅影響並縮短前置作業時間。這些營運措施應輔以靈活的商業模式，將資本收購與基本服務和軟體收益分開，為買家提供符合其預算和臨床時間表的選擇。

其次，我們將透過有針對性的檢驗研究累積臨床證據，證明其在主動脈造影、心血管評估、顱內病變特徵描述和周邊肢體評估等關鍵用例中的比較表現。第三，我們將投資培訓和變革管理項目，幫助放射科團隊和技術人員從新的序列和基於人工智慧的工具中獲得最大的診斷價值。第四，我們將制定區域上市計劃，以反映報銷現狀、監管差異以及高場和低場系統不同的採用曲線。最後，我們將積極與付款人、衛生系統和臨床協會合作，闡明基於磁振造影血管攝影 (MRA) 的途徑的臨床和經濟價值，從而為永續的採用和推廣創造有利環境。

對混合方法研究途徑，該方法結合了二次審查、一次訪談和嚴格檢驗，以確保可靠的 MRA 見解

本研究綜合了透過強調三角測量和相關人員檢驗的混合方法收集的見解。二次分析包括對同行評審的臨床文獻、技術白皮書、監管備案文件和公共採購文件的系統性回顧，以確定序列開發、現場人員利用和臨床實踐的趨勢。一次研究包括與隨機抽樣的放射科醫生、血管外科醫生、影像技術人員、醫院採購負責人和影像提供者的高級管理人員進行結構化訪談和討論，以確保涵蓋臨床、營運和商業領域的多元化觀點。

透過主題編碼和比較分析整合定量和定性數據，並特別關注定序績效指標、操作限制和採購考量。透過與臨床和採購相關人員的後續討論檢驗研究結果，以確認其與實際工作流程的相關性並完善解釋。在整個過程中，我們注意對原始資訊進行匿名化處理，並記錄方法學假設，以確保研究的可重複性和透明度。我們識別了研究的局限性和潛在偏差，確定了需要進一步深入研究的領域，並指南後續研究投入。

技術、臨床和操作因素的結合將決定磁振造影血管造影術是否能夠實現更廣泛的臨床整合和持續的價值創造

磁振造影血管血管造影術正處於技術創新、臨床需求和經濟壓力交會的曲折點。高場和低場系統的進步、非造影和造影增強技術的改進以及人工智慧重建技術的整合，正在拓展磁振造影血管攝影的潛在臨床應用。同時，關稅變化、供應鏈重構和區域採購特性等結構性因素正在重塑組織取得和部署磁振造影血管攝影技術的能力。這兩股力量既創造了價值創造的機會，也催生了策略調整的需求。

展望未來，相關人員產品開發與可證實的臨床結果相結合、保持靈活籌資策略並投資於臨床醫生培訓的利益相關者，將最有能力將技術潛力轉化為常規臨床效益。設備製造商、臨床團隊和影像IT提供者之間的跨學科合作將加速先進血管診斷在日常實踐中的實現。簡而言之，MRA的未來不僅取決於成像性能，還取決於生態系統提供便利、可靠且臨床整合的解決方案的能力。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將人工智慧演算法整合到 MRA 中，實現血管分割和病變量化的自動化
  • 採用高場7T系統提高腦血管影像解析度
  • 針對腎功能不全患者的動脈自旋標記非造影MRA技術的開發
  • 擴展可攜式和照護現場MRI 系統，用於加護病房的床邊血管成像
  • 在 MRA 中實施基於深度學習的降噪可提高影像品質和診斷準確性
  • 緊湊型低場磁振造影血管攝影 (MRA) 掃描儀獲得監管部門核准並進入市場，可用於經濟高效的門診病人血管評估
  • MRI 供應商和雲端服務供應商合作實現即時遠端 MRA 數據分析和遠端醫療整合

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：磁振造影血管血管造影術設備市場（按產品）

  • 配件和耗材
  • 服務
  • 系統
    • 高場強系統
    • 低場強系統

9.磁振造影血管血管造影術設備市場（按場強）

  • 高場強
  • 低場強

第 10 章磁振造影血管血管造影術設備市場（按技術）

  • 對比增強
  • 相襯
  • 靜止間隔單次拍攝
  • 飛行時間

第11章磁振造影血管血管造影術設備市場（按應用）

  • 心血管系統
    • 主動脈
    • 心
  • 神經血管
    • 顱外
    • 顱內
  • 周邊血管
    • 下肢
    • 上肢

第12章磁振造影血管血管造影術設備市場（按最終用戶）

  • 學術研究機構
  • 門診手術中心
  • 診斷影像中心
  • 醫院

第 13 章：磁振造影血管血管造影術設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章磁振造影血管血管造影術設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章。按國家分類的磁振造影血管血管造影術設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Siemens Healthineers AG
    • GE Healthcare, Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Hitachi, Ltd.
    • Fujifilm Holdings Corporation
    • United Imaging Healthcare Co., Ltd.
    • Samsung Medison Co., Ltd.
    • Shimadzu Corporation
    • Esaote SpA
Product Code: MRR-A339DAEFA1A0

The Magnetic Resonance Angiography Market is projected to grow by USD 7.67 billion at a CAGR of 11.38% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.23 billion
Estimated Year [2025] USD 3.60 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 11.38%

Concise framing of how modern magnetic resonance angiography innovations intersect with clinical needs, operational priorities, and organizational decision-making

Magnetic resonance angiography (MRA) occupies a critical nexus between diagnostic imaging innovation and vascular care pathways, offering clinicians noninvasive visualization of blood vessels across a spectrum of clinical settings. Recent technological progress has reduced procedural complexity, expanded clinical indications, and improved patient comfort, thereby elevating MRA from a niche modality to a pivotal diagnostic tool in many vascular workflows. These developments, driven by sequence innovation, hardware evolution, and software-enabled image reconstruction, have reshaped clinician expectations and procurement priorities.

Consequently, stakeholders across imaging departments, clinical research units, and device manufacturing must reassess how MRA integrates with broader diagnostic strategies. Radiology teams are increasingly prioritizing throughput and diagnostic confidence, while hospital administrators seek modalities that support multi-disciplinary uses and predictable lifecycle costs. At the same time, ambulatory centers and diagnostic imaging providers are evaluating how MRA can enhance service portfolios without imposing unsustainable operational burdens. This introduction situates MRA within the contemporary clinical and commercial landscape, emphasizing the interplay between technological capability, clinical uptake, and organizational decision-making.

Detailed exploration of the converging hardware, sequence, and computational trends that are redefining magnetic resonance angiography practice and procurement

The MRA landscape is experiencing transformative shifts driven by converging advances in hardware, pulse-sequence design, and computational imaging. High-field systems continue to push signal-to-noise boundaries and enable higher spatial resolution, yet parallel progress in low-field systems has revived interest due to cost-of-ownership advantages and improved accessibility. Simultaneously, non-contrast techniques such as time-of-flight and quiescent interval single shot have matured to reduce reliance on gadolinium-based agents, reshaping clinical protocols for patients with renal impairment and those requiring repeated imaging.

In parallel, phase contrast sequences and advanced contrast-enhanced methods have been refined for hemodynamic assessments, facilitating more nuanced evaluation of vascular flow and lesion characterization. Artificial intelligence and machine learning now play an increasingly central role in reconstruction, denoising, and automated vessel segmentation, shortening scan times and enhancing diagnostic yield. As a result, service models and consumable workflows are adapting to support hybrid offerings that combine high-end systems, optimized sequence libraries, and value-added software. These shifts collectively redefine procurement criteria and clinical pathways, making interoperability, upgradeability, and software licensing as influential as baseline hardware specifications.

Assessment of how new 2025 tariff measures in the United States are reshaping procurement strategies, supply chains, and capital planning across the magnetic resonance angiography ecosystem

The introduction of new tariffs in the United States in 2025 creates a complex environment for MRA stakeholders, affecting procurement cycles, sourcing decisions, and supplier relationships. Tariff-related cost pressures can raise the landed price of imported components and finished imaging systems, which in turn influences capital allocation and replacement timelines for hospitals, diagnostic centers, and ambulatory facilities. Faced with higher acquisition costs, many purchasers may defer upgrades or prioritize modular investments that can be staged over time, while others will scrutinize total cost of ownership more intensely, including maintenance contracts and consumable supply agreements.

Furthermore, tariff policies incentivize strategic supplier diversification and nearshoring, prompting manufacturers to reconfigure supply chains to mitigate exposure to tariff volatility. For service providers and consumable suppliers, tariffs may alter competitive dynamics as local production becomes relatively more attractive. In this context, procurement teams and clinical leaders must factor supply chain resilience into sourcing criteria, balancing potential short-term cost savings against the risks of single-source dependencies. Regulatory compliance and customs optimization will therefore assume greater importance, and stakeholders should be prepared to engage suppliers on inventory planning and contract flexibility to absorb episodic tariff impacts. Taken together, these adjustments will shape capital planning, vendor negotiations, and operational continuity throughout the imaging ecosystem.

In-depth segmentation synthesis revealing how product types, field strength tiers, imaging technologies, clinical applications, and end-user profiles collectively shape MRA demand and investment

A granular understanding of market segmentation illuminates where clinical demand and investment converge across the MRA landscape. When the market is parsed by product, distinct value streams emerge between accessories and consumables, ongoing service arrangements, and capital systems, with systems themselves bifurcating into high field strength and low field strength platforms that deliver different clinical capabilities and lifecycle economics. This dichotomy is mirrored when segmentation is organized by field strength alone, as high field strength and low field strength platforms each address separate clinical use cases and institutional budgets. Technology-based segmentation reveals how Contrast Enhanced procedures coexist alongside Phase Contrast methodologies, Quiescent Interval Single Shot techniques, and Time Of Flight approaches, each contributing unique diagnostic strengths and sequence-specific workflow requirements.

Application-focused segmentation further clarifies clinical trajectories, with cardiovascular applications encompassing both aortic and cardiac imaging needs, neurovascular practice differentiating between extracranial and intracranial indications, and peripheral vascular use cases delineating imaging of lower limb and upper limb territories. These clinical partitions interact with end-user categories, including academic research institutes, ambulatory surgical centers, diagnostic imaging centers, and hospitals, which vary markedly in procurement cycles, clinical throughput expectations, and staffing models. Consequently, product, field strength, technology, application, and end-user segments create overlapping demand pockets; by tracing these intersections, stakeholders can prioritize investments, tailor service offerings, and design clinical validation studies that resonate with the operational realities of each segment.

Comprehensive regional analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption patterns, procurement dynamics, and clinical priorities for MRA

Regional dynamics exert a profound influence on technology adoption, reimbursement frameworks, and clinical practice patterns across the global MRA landscape. In the Americas, clinical networks and large health systems often drive early adoption of high-performance systems and advanced sequence libraries, while variations in payer models and hospital funding introduce distinct procurement rhythms. Europe, Middle East & Africa present a heterogeneous mix of mature markets with established reimbursement pathways alongside emerging healthcare systems that prioritize cost-effective, scalable solutions; regulatory harmonization efforts and cross-border clinical collaborations further shape demand in these territories. Asia-Pacific exhibits rapid uptake in urban centers driven by expanding diagnostic infrastructures and increasing investment in noninvasive vascular diagnostics, yet market maturation varies widely between high-income metropolitan areas and resource-constrained regions where low-field systems and streamlined service models may be more practical.

Across these geographies, differences in clinical guidelines, training pipelines, and service delivery models influence how MRA is positioned relative to alternative imaging modalities. Vendors and service providers should therefore adopt region-specific engagement strategies that account for procurement cycles, local clinical champions, and regional regulatory considerations. Moreover, partnerships with regional research institutions and targeted clinical education programs can accelerate adoption where clinical demand and capacity align, while flexible commercial models can help bridge gaps in regions with constrained capital availability.

Strategic competitive analysis highlighting how integrated hardware, software, and service propositions determine vendor success in magnetic resonance angiography markets

Competitive dynamics in the MRA ecosystem are increasingly defined by integrated offerings that combine hardware, sequence libraries, post-processing software, and service contracts rather than standalone equipment sales. Original equipment manufacturers who can complement systems with robust software toolkits for vessel segmentation, flow quantification, and AI-enhanced reconstruction secure stronger footholds among large health systems that prize interoperability and roadmap clarity. Simultaneously, specialist vendors focused on consumables, coils, and procedural accessories compete on the basis of clinical compatibility, ease of integration, and predictable supply chains. Service providers that deliver responsive maintenance, remote diagnostics, and flexible training programs add tangible value for end users seeking uptime assurance and staff competency.

Strategic partnerships between imaging IT providers and clinical networks are also emerging as a differentiator, enabling longitudinal data analytics and quality improvement initiatives that extend the clinical utility of MRA. In this environment, companies that invest in clinical validation, provide transparent upgrade paths, and demonstrate strong regulatory compliance are better positioned to win complex, multi-stakeholder procurement decisions. For smaller firms, focusing on niche clinical applications, compelling economic value propositions, or novel contrast and non-contrast techniques can create defensible market positions. Ultimately, success rests on aligning product and service innovations with the operational realities of diverse clinical environments while managing supply chain and tariff-related risks through adaptive sourcing strategies.

Actionable strategic framework for industry leaders to optimize technology investments, supply chains, clinical validation, and commercialization of MRA solutions

Industry leaders should pursue a multi-pronged strategy to capture clinical value and mitigate external risks while accelerating MRA adoption across care settings. First, prioritize investments in sequence and software development that materially reduce scan time and enhance diagnostic confidence, enabling stronger clinical ROI narratives. Concurrently, diversify supply chains and explore regional manufacturing or assembly partnerships to buffer tariff exposure and improve lead times. These operational moves should be complemented by flexible commercial models that decouple capital acquisition from essential service and software revenues, giving purchasers options that align with their budget and clinical schedules.

Second, cultivate clinical evidence through targeted validation studies that demonstrate comparative performance across key use cases such as aortic imaging, cardiac vascular assessment, intracranial lesion characterization, and peripheral limb evaluation. Third, invest in training and change management programs to ensure radiology teams and technologists can extract maximum diagnostic value from new sequences and AI-based tools. Fourth, develop region-specific go-to-market plans that reflect reimbursement realities, regulatory nuances, and the varying adoption curves of high field versus low field systems. Finally, engage proactively with payers, health systems, and clinical societies to articulate the clinical and economic value of MRA-based pathways, thereby creating a supportive environment for sustainable adoption and scale.

Transparent description of the mixed-methods research approach combining secondary review, primary interviews, and rigorous validation to ensure reliable MRA insights

This research synthesizes insights gathered through a mixed-methods approach that emphasizes triangulation and stakeholder validation. Secondary analysis included a systematic review of peer-reviewed clinical literature, technical whitepapers, regulatory filings, and public procurement documentation to establish trends in sequence development, field strength utilization, and clinical practice. Primary research comprised structured interviews and consultations with a purposive sample of radiologists, vascular surgeons, imaging technologists, hospital procurement officers, and senior executives from imaging providers, ensuring diverse perspectives across clinical, operational, and commercial domains.

Quantitative and qualitative data were integrated through thematic coding and comparative analysis, with particular attention paid to sequence performance metrics, operational constraints, and purchasing considerations. Findings were validated through follow-up discussions with clinical and procurement stakeholders to confirm practical relevance and to calibrate interpretations against real-world workflows. Throughout the process, care was taken to anonymize primary-source inputs and to document methodological assumptions, enabling reproducibility and transparency. Limitations and potential biases are acknowledged, and areas identified for further primary study are noted to guide subsequent research investments.

Synthesis of technological, clinical, and operational factors that will determine whether magnetic resonance angiography achieves broader clinical integration and sustained value creation

Magnetic resonance angiography sits at an inflection point where technical innovation, clinical demand, and economic pressures converge. Advancements in both high-field and low-field systems, refinements in non-contrast and contrast-enhanced techniques, and the integration of AI-driven reconstruction are collectively expanding the modality's clinical applicability. At the same time, structural factors such as tariff changes, supply chain reconfiguration, and regional procurement idiosyncrasies are reshaping how organizations acquire and deploy MRA capabilities. These dual forces create both opportunities for value creation and imperatives for strategic adaptation.

Looking ahead, stakeholders that align product development with demonstrable clinical outcomes, maintain flexible sourcing strategies, and invest in clinician training will be best positioned to translate technological potential into routine clinical benefit. Cross-disciplinary collaboration between device manufacturers, clinical teams, and imaging IT providers will accelerate the realization of advanced vascular diagnostics in everyday practice. In short, MRA's future will be defined not only by imaging performance but also by the capacity of the ecosystem to deliver accessible, reliable, and clinically integrated solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms in MRA for automated vessel segmentation and lesion quantification
  • 5.2. Adoption of high-field 7T magnetic resonance angiography systems for improved cerebrovascular imaging resolution
  • 5.3. Development of non-contrast-enhanced MRA techniques using arterial spin labeling for patients with renal impairment
  • 5.4. Expansion of portable and point-of-care MRI systems for bedside vascular imaging in critical care settings
  • 5.5. Implementation of deep learning-based noise reduction in MRA to enhance image quality and diagnostic accuracy
  • 5.6. Regulatory approval and market entry of compact low-field MRA scanners for cost-effective outpatient vascular assessments
  • 5.7. Collaboration between MRI vendors and cloud service providers for real-time remote MRA data analysis and telemedicine integration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Angiography Market, by Product

  • 8.1. Accessories And Consumables
  • 8.2. Service
  • 8.3. Systems
    • 8.3.1. High Field Strength System
    • 8.3.2. Low Field Strength System

9. Magnetic Resonance Angiography Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength

10. Magnetic Resonance Angiography Market, by Technology

  • 10.1. Contrast Enhanced
  • 10.2. Phase Contrast
  • 10.3. Quiescent Interval Single Shot
  • 10.4. Time Of Flight

11. Magnetic Resonance Angiography Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Aortic
    • 11.1.2. Cardiac
  • 11.2. Neurovascular
    • 11.2.1. Extracranial
    • 11.2.2. Intracranial
  • 11.3. Peripheral Vascular
    • 11.3.1. Lower Limb
    • 11.3.2. Upper Limb

12. Magnetic Resonance Angiography Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Ambulatory Surgical Center
  • 12.3. Diagnostic Imaging Center
  • 12.4. Hospital

13. Magnetic Resonance Angiography Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Magnetic Resonance Angiography Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Magnetic Resonance Angiography Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Siemens Healthineers AG
    • 16.3.2. GE Healthcare, Inc.
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Hitachi, Ltd.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. United Imaging Healthcare Co., Ltd.
    • 16.3.8. Samsung Medison Co., Ltd.
    • 16.3.9. Shimadzu Corporation
    • 16.3.10. Esaote S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MAGNETIC RESONANCE ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (